A 30-year-old cure with baicalein can heal all patients with Corona, AIDS, Dengue and other retroviruses. Baicalein also cures flu, all cancers, all infections, septic shocks, cerebral hemorrhages, Parkinson– and Alzheimer diseases, Multiple sclerosis, dementia, diabetes, rheumatism, some heart-, neurological- and vascular diseases etc., etc., because all those diseases are based on causative microbes and baicalein inhibits a few essential enzymes in those microbes, helping curing many inflammatory diseases.
Baicalein is not used for those diseases, because those treatments without side effects are too effective, efficient, safe, good and cheap and because baicalein is not patentable.
Due to non-patentability, the AMA (American Medical Association), FDA (Food and Drug Adminitration) and big Pharma do not allow structural medical research with baicalein and since 1990 hundreds of millions of people with unnecessary pain and emotions prematurely died, while that could be prevented.
Baicalein is an herb that is produced from the roots of the plants Scutellaria baicalensis and Scutellaria lateriflora. Today, baicalein can be made synthetic and a few patent citations are added as references to read against which diseases baicalein is found to be effective.
In the article of K. Ono et al. published in 1990, the authors report that AIDS can be cured with baicalein. In 1990 that should have been world news, but worldwide this cure was suppressed by the AMA and FDA in favor of the big Pharma and their selves. In the same period they also suppressed dr. G. Naessens, who was using kaempferol (camphor, a flavonoid just like baicalein) with which he also cured AIDS patients.
In 1990 dr S. Kaali and dr W. Lyman invented the cure to kill viruses in blood with small current pulses. Dr B. Beck improved this method and with his Doctor Bob Beck Protocol and Blood Optimizer he healed hundreds of patients with a wide variety of diseases including cancers, AIDS and other virus infections.
The main news since 1990, which has been published for more than 30 years, was that AIDS was incurable and yet no effective medicine or method was available.
The same crime against humans and humanity as with the HIV virus happens 30 years later in 2020 with the Corona virus. The WHO, AMA, FDA and big Pharma do not have an effective drug and worldwide they prematurely kill thousands of people, they, with their governments in their pockets, shut down entire economies in almost every country of the world, they prevent all traveling’s, closed many borders and in some countries no one is allowed to leave their house, while the Corona patients can be cured with 6 euro cents or less per treatment.
How kills baicalein retroviruses and cancer microbes?
In retroviruses baicalein inhibits the enzyme reverse transcriptase, whereby their RNA cannot be converted into DNA, so that in the infected patient this DNA cannot make new Corona proteins and the virus cannot multiply.
The literature describes baicalein as being an anti-viral agent.
Baicalein also strongly inhibits the enzyme glyoxalase 1, which means that in the cells methylglyoxal no longer enzymatically is broken down. Methylglyoxal in turn now irreversibly inhibits the microbial enzyme malate synthase. Almost all bacteria, macro viruses, fungi, yeasts, protozoa and other single-celled organisms use the enzyme malate synthase for their energetic metabolism, which now is completely stopped by methylglyoxal. As result, they die from a shortage of ATP. ATP is the universal energy source for all life on earth. With this treatment, opportunistic infections no longer occur because all pathogenic microbes simultaneously are killed.
Humans and animals do not have the enzyme malate synthase and therefore do not suffer from this inhibition. Thus, methylglyoxal is very specific against microbes, which have the glyoxal cycle for their energetic metabolism. This includes almost all pathogens in humans and animals and in the literature baicalein also is described being an anti-cancer and anti-bacterial agent.
In 1913 prof. dr W.F. Koch injected methylglyoxal in patients with tumors and healed them. In addition to many tumors, in the 1950’s he could cure a total of 67 incurable diseases, including multiple sclerosis. From 1920 AMA and FDA banned methylglyoxal and prof. dr W.F. Koch and with this action a 50-year battle started against prof. dr W.F. Koch.
Fortunately, around 1960, the Nobel Prize winner dr A. Szent-Györgyi continued researching methylglyoxal and so with methylglyoxal again we have a universal cure against all microbes, who obtain energy from their glyoxal cycle. Almost all microbes use this cycle, including many causing cancer.
Baicalein prevents broken down the body’s own produced methylglyoxal by inhibiting glyoxalase 1 and thus methylglyoxal does its inhibiting effect with the enzyme malate synthase.
With baicalein and methylglyoxal, we have two natural products at our disposal who can kill a wide range of pathogenic microbes in humans and animals, in the near future saving millions of lives.
After 30 and 107 years of suppression let’s take a closer look at both, because baicalein also traps radicals in our body and does much more.
Figure: ijms-17-01681-g002.jpg from the paper: the Fascinating Effects of Baicalein on Cancer, see the references.
Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. Katsuhiko Ono, Hideo Nakane, Masanori Fukushima, Jean-Claude Chermann and Franqoise Rarre-Sinouss. Eur. J. Riochem. 190,469-476 (2990) FEBS 1990
In Vitro Inhibition of Glyoxalase І by Flavonoids: New Insights from Crystallographic Analysis. Hong Zhang, Jing Zhai, Liping Zhang, Cuiyun Li, Yining Zhao, Yunyun Chen, Qing Li* and Xiao Peng Hu. Current Topics in Medicinal Chemistry, 2016, 16, 000-000
Inhibitory Effects of Baicalein on the Influenza Virus in Vivo Is Determined by Baicalin in the Serum. Ge XU, Jie DOU, Lei ZHANG, Qinglong GUO and Changlin ZHOU. Biol. Pharm. Bull. 33(2) 238—243 (2010)
Application of radix scutellariae and flavonoid against sub-type infection of influenza virus A (H1N1). Patent CN101797246B
New medical application of baicalein and its prodrugs. Patent CN104622866A
Application of baicalein in the medicine for preparing prevention and/or treatment nasopharyngeal carcinoma. Patent CN107334763A
Use of baicalein as prolyl hydroxylase inhibitor. Patent US20100004325A1
The synergistically pharmaceutical composition of baicalein and baicalin for inhibiting tumor. Patent EP1849467A1
Baicalein and baicalein analogs and uses there off (septic shock). Patent AC2421887A1
Screening Flavonoids for Inhibition of Acetylcholinesterase Identified Baicalein as the Most Potent Inhibitor. Azize Balkis, Khoa Tran, Yan Zhi Lee & Ken Ng. Journal of Agricultural Science; Vol. 7, No. 9; 2015 ISSN 1916-9752 E-ISSN 1916-9760
The Fascinating Effects of Baicalein on Cancer: A Review Hui Liu, Yonghui Dong, Yutong Gao, Zhipeng Du, Yuting Wang, Peng Cheng, Anmin Chen and Hui Huang. Int. J. Mol. Sci. 2016 , 17 (10), 1681
Effects of Baicalein, a Flavonoid, and Other Anti-inflammatory Agents on Glyoxalase-I Activity. Masayoshi IIO, Satomi ISHIMOTO, Yuko NISHIDA, Tomoko SHIRAMIZU, Haruko YUNOKI. https://www.jstage.jst.go.jp/browse/bbb1961/-char/ja
Structure–activity relationship of human GLO I inhibitory natural flavonoids and their growth inhibitory effects. Ryoko Takasawa, Saki Takahashi, Kazunori Saeki, Satoshi Sunaga, Atsushi Yoshimoria,c and Sei-ichi Tanumaa. Bioorganic & Medicinal Chemistry 16 (2008) 3969–3975
Methylglyoxal: Large Response Rate in Very Advanced Stages. Cancer Treatments – from Research to Application, MCS Foundations for Life, In memory of my dear wife Mihaela Catalina Stanciu. Tribute to prof dr W.F. Koch, dr A. Szent-Györgyi, prof. dr M. Ray en dr S. Ray.
» Shared per request